BARCLAYS PLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 312069 LONDON, X0

Position in PYXS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$72,743

+$3,302 QoQ

Shares Held

49,825

-17.5% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 78 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,076,655 across 360 Biotechnology names. PYXS ranks #261 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$72,743	49,825	-17.5%	Shares	Defined	2026-05-15
2025-12-31	$69,441	60,385	+1939.3%	Shares	Sole	2026-02-13
2025-09-30	$6,573	2,961	-39.0%	Shares	Sole	2026-03-31
2025-06-30	$5,339	4,854	-91.0%	Shares	Sole	2026-02-27
2025-03-31	$53,026	54,109	-29.7%	Shares	Sole	2026-03-17
2024-12-31	$120,140	77,013	+20.2%	Shares	Sole	2026-03-19
2024-09-30	$235,206	64,089	+275.0%	Shares	Sole	2026-03-31
2024-06-30	$56,574	17,092	-85.5%	Shares	Sole	2026-03-23
2023-03-31	$474,074	118,223	-87.5%	Shares	Sole	2026-03-30
2022-12-31	$1,270,388	948,051	+0.0%	Shares	Sole	2026-03-30
2022-09-30	$1,866,872	947,651	0.0%	Shares	Sole	2022-11-03
2022-06-30	$2,255,409	947,651	-0.2%	Shares	Sole	2022-08-12
2022-03-31	$3,835,523	949,387	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.